Prevalence of Trichomoniasis and Vulvovaginal Candidiasis Among Married Women in Duhok City, Kurdistan Region, Iraq

Document Type : Original Articles

Author

Medical Laboratory Sciences Department, College of Health Sciences/ University of Duhok, Iraq.

10.32592/ARI.2024.79.2.303

Abstract

Trichomonas vaginalis (T. vaginalis) and candida (C.) species are the most common causes of vaginal infections in reproductive-age women. T. vaginalis is a sexual protozoa parasite that causes trichomoniasis. Candida species are fungal and cause an infection in the female genital tract named candidiasis caused by several Candida species. Both microorganisms if not treated correctly may lead to many complications such as abortion, premature delivery, disorders of menstrual cycle, and infertility. The current study aimed to study the frequency of T. vaginalis and Candida species including C. albicans, C. krusei, and C. glabrata infections among females with vaginal infection in Duhok City, Kurdistan region, Iraq. About 250 vaginal swabs were collected from women that attended to the Vin Private Laboratory and 150 samples were collected from women that attended to the Arveen Private Laboratory have vaginal infections. Out of these 400 vaginal swabs samples, twenty-four samples were recorded positive for T. vaginalis by direct smear. One hundred ten samples were recorded positive for candidiasis by culturing on the Candida Chromagar. Three species of Candida were isolated including C. albicans, C. krusei, and C. glabrata, their prevalence was (60.9%., 28.25, 7.3%, and 3.6%) respectively. Vaginal infection was commonly found in the age group between 25-35 years (49.6%), followed by the group aged between 35-45 years (36.4%). Also, (3.2%) of samples were found to have a mixed infection with trichomoniasis and candidiasis. Because these two causative agents have many complications in women, therefore it is highly recommended a good control measurement to prevent or decrease vaginal infection such as health education, personal hygiene, and treatment of infected women.

Keywords

Main Subjects


  1. Introduction

Vaginal infections are frequent among women of reproductive age (1). They can result from disorders that cause the overgrowth of endogenous microbiota or from sexually transmitted microorganisms. Candida albicans and Trichomonas vaginalis are two of the more prevalent vaginal microorganisms (2, 3). T. vaginalis is a facultative urogenital flagellate protozoan parasite of humans transmitted sexually and causing a disease named trichomoniasis or trich (4, 5). T. vaginalis is the most prevalent pathogenic protozoan of women in industrialized countries and is responsible for over half of all sexually transmitted infections (2, 6). Women with trichomoniasis frequently have vaginal pH levels above 4.5. However, more than 50% of those with the infection show no symptoms (7). The main symptoms of trich in women with T. vaginalis infection are the experience of moderate to severe cervicitis, vulvovaginitis, urethritis, premature birth or low birth weight, cervical cancer, or more susceptibility to HIV (8, 9). Candida-related fungi are commensals and frequently found in colonizing human skin, the gastrointestinal tract, and the genitourinary system (10). Candida spp. is the second most common cause of vulvovaginitis, after bacterial vaginosis (1, 11). Three out of every four women will experience at least one incident of vulvovaginal candidiasis (VVC) in their lifetimes, and it is approximated that one out of five women has Candida spp. and other types of fungi in their vagina (12, 13). Vulvovaginal candidiasis is known as a condition when there are symptoms of genital irritation or inflammation as well as the presence of Candida spp. without the presence of other etiologies (10). Therefore, the existence of this fungus does not imply an infection. Vulvovaginal candidiasis typically causes burning, itching, and vaginal discharge that resembles curd and pruritus. Candida proliferates better in environments with pH levels between 3.9 and 5.0 (14, 15). Vaginal pH is typically less than 4.5 in cases of VVC (1). This study aimed to compare the prevalence of T. vaginalis and Candida spp. to confirm the coexistence of these two agents.

  1. Materials and Methods

2.1 Sample Collection and Processing:

This study was conducted in Duhok City, Iraq, between August 2022 and May 2023. A total of 400 vaginal swabs were collected from married women with vaginal infections that attended the Vin Private Laboratory (n=250) and Arveen Private Laboratory (n=150), Duhok City, Iraq. Initially, the direct wet smear was prepared for all vaginal swabs and examined under the microscope for screening of T. vaginalis. Following that, all vaginal swabs were cultured first on the blood agar and then sub-cultured on the CHROMagar™ Candida for the detection of Candida species.

2.2 Statistical analysis

The collected data were analyzed in SPSS software (version 15.0).

  1. Results

Of the 400 vaginal swabs tested, 24 (6.0%) were positive for trich, and 110 (27.5%) were positive for candidiasis in married women that attended both Vin and Arveen private laboratories. Table 1 presents the total vaginal swabs collected from women of different ages who attended the Vin and Arveen privates laboratories. Table 2 shows the prevalence of infection of both trichomoniasis and candidiasis. Based on table 2, the infection rate of these diseases dropped with increasing age as follow: infection rate with both diseases were respectively 3.5%, and 18.25% in women in the age group of 25-34, 1.75% and 6.5% in the age group of 35-44, and 0.75% and 2.75% in age groups of 45-55 years old. These results were not significant at P < 0.05. It is shown in table 3 that depending on the wet vaginal swabs and culturing, 24 of 400 vaginal swaps (6.0%) were reported positive for trichomoniasis, 100 vaginal swaps (27.0%) were positive for candidiasis, and 8 vaginal samples (2.5%) were having a mixed infection (trich and candidiasis). During the current study, three species of candida, namely C. albicanis, C. krusei, C. glabrata, were isolated from vaginal swabs by culturing on CHROMagar™ Candida, with a prevalence rate of 60.9%, 7.3%, and 3.6% respectively, as shown in table 4. These results were significant at P < 0.05.

  1. Discussion

The low prevalence of trichomoniasis in this study was similar to the results found in some cities of Iraq. In Erbil City, this rate was (1.66 %) (16) and in Al-Najaf City was (8.05%) (17). These prevalence rates were lower compared to those reported in other countries, such as Polska (62-78%) (18), New York (25%) (19), and South Korea (10.4%) (20). The lower rate of trichomoniasis in this study is attributed to Islam forbidding non-marital relationships in its laws and customs. When compared to more liberal non-Islamic nations, this may be explained by the lower prevalence of this sexually transmitted protozoan infection in Islamic nations. According to reports (21, 22), sexually active women have a greater infection rate, and having multiple partners as well as lifestyle contribute to an increase in transmission.

 

 

       
   
 
     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In the current study, the prevalence rate of trichomoniasis and candidiasis decreased with increasing age. Accordingly, infection rates with both diseases were higher in women in the age group of 25-34 years old, followed by age groups of 35-44 and 45-55 years old. These results were not significant at P < 0.05. These findings were in agreement with those of a study conducted in Baghdad City, Iraq, by Al-Muathenand and Sachit (2016) (23) among non-pregnant and pregnant women. They recorded the highest prevalence rate of both diseases in younger age groups. Furthermore, the decline in the prevalence rate of this disease with aging in the present study was consistent with the results of research carried out by Nourian et al. in Zanjan, Iran, among pregnant women (24). These results may be due to a rise in hormonal and immunologic changes, which together can heighten the susceptibility of vaginal tissue to these infections (25). Additionally, this increase might be partially caused by a low vaginal pH, which is ideal for fungus growth (26, 27). In the current study, although trichomoniasis and candidiasis were more prevalent in the age group of 25-34 years old, there was a modest rise in the number of elderly women who were infected compared to women who were under 40 years old. This finding was in agreement with the results of a study performed by Ali (2012) (24) on menopausal women; however, they were not significant at P > 0.05. The increase among younger women may be attributed to the higher sexual activity rates in this age group (28). These results were inconsistent with our results demonstrating that the most common species of Candida that caused vulvovaginitis in women was C. albicans (60.9%), ranking first, followed by C. krusei (7.3%) and C. glabrata (3.6%). Recently, in Al-Diwaniyah City, Iraq, Al-Sudani and Al-Awsi (2022) recorded the prevalence rates of species C. albicans (47.46%), C. glabrata (27.12%), C. tropicalis (15.25%), and C. krusei (10.17%) among women (28- 29-30); these results were

 

 

 

 

 

 

 

 

 

 

relatively similar to the current study results. Finally, mixed infections (T. vaginalis and Candida) were reported among women. It can be concluded that the age group of 25-35 years old is more susceptible to trichomoniasis and candidiasis than the other age groups. It was also found that the most frequent species of Candida were C. albicans, C. krusei, and C. glabrata, with C. albicans as the most common cause of vulvovaginal candidiasis.

  1.  

    1. Frobenius W, Bogdan C. Diagnostic Value of Vaginal Discharge, Wet Mount and Vaginal pH - An Update on the Basics of Gynecologic Infectiology. Geburtshilfe und Frauenheilkunde. 2015;75(4):355–366. DOI: 10.1055/s-0035-1545909
    2. Angebault C, Djossou F, Abélanet S, Permal E, Ben Soltana M, Diancourt L, et al. Candida albicans is not always the preferential yeast colonizing humans: a study in Wayampi Amerindians. The Journal of infectious diseases. 2013; 208(10): 1705–1716. DOI: 10.1093/infdis/jit389
    3. Workowski KA, Bolan GA, and Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines (2015). MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports. 2015;64(RR-03): 1–137.
    4. Poole DN, McClelland RS. Global epidemiology of Trichomonas vaginalis.Sexually transmitted infections. 2013; 89(6): 418–422. DOI: 10.1136/sextrans-2013-051075
    5. Kissinger P. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC infectious diseases. 2015;15:307. DOI: 10.1186/s12879-015-1055-0
    6. Manshoori A, Mirzaei S, Valadkhani Z, Kazemi Arababadi M, Rezaeian M, Zainodini N, et al. A Diagnostic and Symptomatological Study on Trichomoniasis in Symptomatic Pregnant Women in Rafsanjan, South Central Iran in 2012-13. Iranian journal of parasitology. 2015: 10(3): 490–497.
    7. Sutton M, Sternberg M, Koumans EH, McQuillan G. Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2007; 45(10):1319–1326. DOI: 10.1086/522532
    8. Hobbs MM, Lapple DM, Lawing LF, et al. Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. Journal of clinical microbiology. 2006; 44(11):3994-3999. DOI: 10.1128/JCM.00952-06
    9. Kazemi F, Hooshyar H, Zareikar B, Bandehpour M, Arbabi M, Talari S, et al. Study on ITS1 Gene of Iranian Trichomonas vaginalis by Molecular Methods. Iranian Journal of Parasitology. 2010; 5(4): 9–14.
    10. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clinical microbiology reviews. 2010; 23(2): 253–273. DOI: 10.1128/CMR.00076-09
    11. Sobel JD. Sexually Transmitted Infections and Sexually Transmitted Diseases. Berlin, Heidelberg: Springer Berlin Heidelberg; 2011. Genital Candidiasis; pp. 613–24.
    12. De Bernardis F, Arancia S, Sandini S, Graziani S, Norelli S. Studies of Immune Responses in Candida vaginitis. Pathogens. 2015; 4(4):697-707. Published 2015. DOI:10.3390/pathogens4040697. DOI: 10.3390/pathogens4040697
    13. Sobel JD. Recurrent vulvovaginal candidiasis. American journal of obstetrics and gynecology. 2016; 214(1):15–21. DOI: 10.1016/j.ajog.2015.06.067
    14. Rodrigues MT, Gonçalves AC, Alvim MC, Castellano Filho DS, Zimmermmann JB, da Silva VL, Diniz CG. Associação entre cultura de secreção vaginal, características sociodemográficas e manifestações clínicas de pacientes com diagnóstico de candidíase vulvovaginal [Association between vaginal secretion culture, socio-demographic characteristics and clinical manifestations of patients with vulvovaginal candidiasis]. Revista brasileira de ginecologia e obstetricia: revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2013; 35(12): 554–561. DOI: 10.1590/s0100-72032013001200005
    15. Du H, Huang G. Environmental pH adaption and morphological transitions in Candida albicans. Current genetics. 2016; 62(2): 283–286. DOI: 10.1007/s00294-015-0540-8
    16. Kadir MA, Fattah COD. Trichomonas vaginalis among women in Sulaimania Governorate-Iraq, Tikrit. Journal of Pharmaceutical Science. 2010; 6:1-9
    17. Naama J, Hasson F, Abdullah E. Detection of Trichomonas vaginalis among women with contraceptive usage in Al-Najaf Alashraf City .The-Qar Medical Journal. 2008; 2:46- 50.
    18. Kurnatowska A, Mamos AR. Prevalence of Trichomonas vaginalis Donné in women of Lódź population in 1955-1999 years. Was Parasitology. 2001; 47(1): 9-12.
    19. Schwebke J, Burgess D.  Trichomoniasis, Clinical Microbiology Reviews. 2004; 17(4):794–803.
    20. Ryu JS, Min DY. Trichomonas vaginalis and trichomoniasis in the Republic of Korea. Korean Journal of Parasitology. 2006; 44(2) 101- 116
    21. Bowden FJ, Garnett GP. Trichomonas vaginalis epidemiology: parameter rising and analyzing a model of treatment intervention. Sexuall Transmitted Infection. 2000;  76:248-256.
    22. Verteramo R, Calzolari E, Degener AM, Masciangelo R, Patella A. Trichomonas vaginalis infection: risk indicators among women attending for routine gynecologic examination. Journal of Obstertrics and Gynaecology Research. 2008; 34:233-237.
    23. Nourian A, Shbani N, Fazaeli A, Mousavinasab SN. Prevalence of Trichomonas vaginalis in Pregnant Women in Zanjan, Northwest of Iran. Jundishapur Journal of Microbiology. 2013; 6(8):e77258
    24. Ali SF. Incidence of Trichomonas vaginalis infection   after   menopause age    of    Al-Taqani.    2012; 25(2):16-20
    25. DolgushinaVF, Telesheva LF, Dolgushina II. The local immunity of genital system   in   pregnant   women with   a   genital    Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2000; 2: 92-5
    26. Gentry LO, Price MF. Urinary and genital candida infections. In: Candidiasis.Body GP, FainsteinV. Raven press, New  5thed.1985;166-69
    27. Fetouh, M., Elbarbary, H., Ibrahim, E., Maarouf, A. Effect of Adding Lactoferrin on Some Foodborne Pathogens in Yogurt. Iranian Journal of Veterinary Medicine, 2023; 17(3): 189-198. doi: 10.32598/ijvm.17.3.1005313
    28. AL-Muathenand DM, Sachit HG. PrevalenceTrichomoniasis and Candidiasis For Symptomatic Pregnant and Non Pregnant Women in Iraq. Al-Mustansiriyah Journal of Pharmaceutical Sciences. 2016: 16(2): 21-26
    29. Alsudani AA, Al-Awsi GRL. Detection of Candida Spp. that cause vulvovaginitis in women that use contraceptive methods. Wiadomosci lekarskie (Warsaw, Poland: 1960),2022;75(8pt2):1965-1969. doi:10.36740/WLek202208204
    30. Hosseinabdai, E., Talebkhan Garoussi, M., Khosravi, A. R., Gharaghozloo, F., Khorramian Toosi, B., Moosakhani, F. Prevalence of Prototheca and Fungal Contamination of Bulk Milk Tank of Industrial Dairy Cattle Herds in Iran. Iranian Journal of Veterinary Medicine, 2022; 16(2): 155-165. doi: 10.22059/ijvm.2021.327607.1005187
    31. Peidaei, F., Ahari, H., Anvar, S. A. A., Ataee, M. Nanotechnology in Food Packaging and Storage: A Review. Iranian Journal of Veterinary Medicine, 2021; 15(2): 122-153. doi: 10.22059/ijvm.2021.310466.1005130